+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Synthesis Market - Global Forecast 2026-2032- Product Image
Gene Synthesis Market - Global Forecast 2026-2032- Product Image
Sale

Gene Synthesis Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • July 2026
  • Region: Global
  • 360iResearch™
  • ID: 5715509
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gene Synthesis Market is projected to reach USD 3.02 Billion in 2026. It is expected to continue growing at a CAGR of 16.29%, reaching USD 7.51 Billion by 2032.

Gene synthesis is the enzymatic and chemical construction of DNA sequences from digital designs, enabling researchers and manufacturers to obtain custom genes, gene fragments, libraries, regulatory elements, and pathway components without relying on natural templates. The field has become a foundational capability for synthetic biology, vaccine research, precision medicine, agricultural biotechnology, industrial enzymes, diagnostics, and cell and gene therapy development. Demand is being shaped by the need for faster design-build-test-learn cycles, higher sequence accuracy, scalable oligonucleotide assembly, and reliable delivery of complex constructs such as high-GC sequences, repetitive regions, antibody libraries, CRISPR components, and codon-optimized genes. Regulatory and biosecurity expectations are also central to adoption, as providers and users increasingly align with sequence screening, customer verification, documentation, and quality control practices to reduce misuse risk while supporting legitimate research. In this environment, the gene synthesis landscape is defined by technical performance, turnaround time, data integrity, compliance readiness, and the ability to integrate synthesized DNA into downstream workflows such as cloning, expression, genome editing, mRNA template production, and functional genomics.

Transformative Shifts in the Gene Synthesis Landscape

The gene synthesis landscape is undergoing a structural shift from transactional DNA ordering toward integrated, automated, and quality-driven biological design infrastructure. Advances in high-throughput oligonucleotide synthesis, error correction, next-generation sequencing-based quality assessment, and automated cloning are improving the reliability of synthetic constructs while reducing manual bottlenecks. At the same time, users are moving beyond single-gene projects into multiplexed libraries, pathway engineering, protein optimization, and large-scale variant generation, which places greater emphasis on informatics, design rules, and workflow interoperability. The expansion of synthetic biology into therapeutics, sustainable chemicals, food technology, and bio-based manufacturing is also increasing scrutiny of reproducibility, traceability, and biosafety controls. Public health experience with rapid vaccine platform development has reinforced the strategic value of rapid DNA synthesis, while global biosecurity discussions have made responsible sequence screening a core operational expectation. These shifts are creating a more mature environment in which service reliability, secure digital ordering, validated quality metrics, and compatibility with automated laboratory platforms are as important as synthesis capacity itself.

Cumulative Impact of Artificial Intelligence on Gene Synthesis

Artificial intelligence is materially changing gene synthesis by improving how sequences are designed, optimized, screened, and integrated into biological systems. AI-enabled models support codon optimization, promoter and ribosome binding site selection, protein sequence design, antibody and enzyme engineering, metabolic pathway balancing, and prediction of synthesis difficulty. Machine learning is also used to identify problematic motifs, secondary structures, repeats, extreme GC content, and sequences associated with low assembly success, helping users redesign constructs before ordering. In the laboratory, AI-assisted automation can improve planning for oligonucleotide pools, assembly strategies, error correction, and quality control interpretation. The most significant cumulative impact is the compression of the design-build-test-learn cycle: digital models generate more testable hypotheses, synthesized DNA translates those designs into physical constructs, and experimental results feed back into improved models. However, AI also heightens the need for governance because more powerful design tools can lower barriers to creating biologically active sequences. Responsible adoption therefore depends on combining AI-driven productivity with sequence screening, auditability, customer due diligence, secure data handling, and alignment with evolving biosafety and biosecurity guidance.

Key Regional Insights for Gene Synthesis

Asia-Pacific is becoming a major center for gene synthesis adoption due to expanding biotechnology manufacturing, government-supported life science programs, growing academic research output, and increasing use of synthetic biology in healthcare, agriculture, and industrial biotechnology. China, India, Japan, South Korea, Australia, and ASEAN economies are strengthening capabilities in genomics, vaccine development, biomanufacturing, and precision medicine, creating sustained demand for custom DNA and gene library services. Europe demonstrates strong demand linked to pharmaceutical research, industrial biotechnology, academic consortia, and policy emphasis on responsible innovation, data governance, and biosafety, while North America remains highly influential because of its concentration of advanced biomedical research, cell and gene therapy development, synthetic biology innovation, venture-backed biotechnology activity, and strong demand from universities, research hospitals, and contract research ecosystems. Latin America is progressing through expanding genomics initiatives, infectious disease research, agricultural biotechnology, and public health applications, with Brazil and Mexico playing important roles in research capacity and biomanufacturing interest. Africa’s gene synthesis opportunity is connected to pathogen surveillance, vaccine research, crop improvement, and capacity building in genomics, although infrastructure, funding continuity, and specialized workforce availability remain key constraints across many markets. The Middle East is increasing investment in genomics, healthcare transformation, and biotechnology infrastructure, particularly in nations pursuing diversification through life sciences and advanced medical research.

Key Group Insights for Gene Synthesis

NATO member states are relevant to gene synthesis because the technology intersects with biodefense, pathogen preparedness, secure supply chains, and dual-use research governance, increasing the importance of responsible DNA synthesis standards and trusted screening practices across allied research ecosystems. G7 countries continue to shape advanced use cases in synthetic biology, precision medicine, vaccine platforms, biologics development, and biosecurity policy, supported by mature research infrastructure and significant public and private life science investment. BRICS economies collectively represent a diverse gene synthesis growth base, combining China and India’s large research and manufacturing ecosystems, Brazil’s agricultural biotechnology strengths, Russia’s life science research base, and South Africa’s role in regional biomedical and public health research. The European Union provides a highly regulated and research-intensive environment in which gene synthesis supports pharmaceutical development, industrial biotechnology, food and agriculture innovation, and cross-border academic programs, with strong attention to quality systems, data protection, and biosafety. ASEAN countries are increasingly relevant as regional governments support biomedical research, vaccine readiness, agricultural biotechnology, and university-industry collaboration, while Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines contribute to broader demand for genomics and synthetic biology capabilities. The GCC is advancing gene synthesis-related activity through national healthcare modernization, genomic medicine initiatives, research hospital development, and long-term strategies to build biotechnology capacity as part of economic diversification.

Key Country Insights for Gene Synthesis

China is a major force in genomics, synthetic biology, biomanufacturing, and applied biotechnology, while the United States leads in advanced gene synthesis utilization through deep synthetic biology, pharmaceutical, academic, defense health, and cell and gene therapy ecosystems, with strong emphasis on rapid prototyping, automated workflows, and biosecurity-aware screening. Japan focuses on precision life sciences, industrial biotechnology, and high-quality research systems, and India is expanding rapidly through vaccine production, biopharmaceutical research, bioinformatics talent, and agricultural biotechnology. Germany supports demand through industrial biotechnology, pharmaceutical research, and engineering-led life science innovation, while the United Kingdom maintains strength in genomics, synthetic biology, and translational medicine. Australia supports gene synthesis demand through medical research, infectious disease preparedness, agriculture, and university-led biotechnology, while France emphasizes biomedical research, vaccines, and biomanufacturing. South Korea is advancing through biologics manufacturing, genomics, diagnostics, and strong national investment in biotechnology innovation, while Italy and Spain contribute through academic genomics, clinical research, and biotechnology clusters. Canada contributes through genomics research, vaccine development, agricultural biotechnology, and public research networks, while Russia remains active in molecular biology, vaccine science, and research applications despite geopolitical and supply chain constraints. Brazil is a key Latin American hub for gene synthesis applications in agriculture, infectious disease research, and bioeconomy development, and Mexico’s demand is linked to biotechnology education, diagnostics, agricultural research, and integration with North American life science supply chains.

Actionable Recommendations for Gene Synthesis Leaders

Industry leaders should prioritize integrated gene synthesis workflows that connect digital sequence design, biosafety screening, automated ordering, construct assembly, sequencing-based verification, and downstream cloning or expression services. Investment in AI-enabled design tools should be paired with transparent validation, secure data governance, and human oversight for dual-use risk management. Organizations should strengthen quality systems for sequence accuracy, documentation, batch traceability, contamination control, and reproducibility, particularly when serving regulated applications such as therapeutics, diagnostics, and vaccine development. Providers and users should adopt recognized responsible DNA synthesis practices, including customer verification and screening for sequences of concern, while maintaining clear escalation processes for ambiguous requests. To improve competitiveness, leaders should develop capabilities for difficult sequences, long constructs, multiplexed libraries, codon optimization, and application-specific formats such as CRISPR templates, antibody libraries, and mRNA production templates. Strategic partnerships with academic centers, biomanufacturing facilities, public health networks, and automation platform providers can accelerate adoption. Organizations should also reduce supply chain risk by diversifying critical reagents, improving regional service resilience, and aligning operations with local data, biosafety, and import-export requirements.

Research Methodology

This executive summary is developed through secondary research and analytical synthesis of verified public-domain information from scientific literature, regulatory guidance, public health sources, industry standards discussions, patent and innovation trends, government biotechnology strategies, and documented developments in genomics, synthetic biology, and biosecurity governance. The methodology focuses on qualitative evidence rather than market sizing, market share, or forecasting. Key themes were assessed across technology evolution, application demand, regulatory and biosafety considerations, regional research capacity, manufacturing readiness, and adoption drivers. Regional, group, and country insights were structured using observable indicators such as public investment in life sciences, genomics initiatives, biomanufacturing activity, academic and clinical research ecosystems, agricultural biotechnology relevance, and policy emphasis on responsible innovation. AI-related analysis was based on documented use cases in sequence optimization, protein engineering, library design, automation, and dual-use risk mitigation. Findings were cross-checked for consistency across credible sources, and speculative claims or unsupported numerical projections were excluded to maintain reliability and executive relevance.

Conclusion

Gene synthesis has evolved into a strategic enabler of modern biotechnology, linking digital biological design with physical DNA construction for applications across medicine, agriculture, industrial biotechnology, diagnostics, and public health. The field is being reshaped by automation, AI-driven sequence design, higher expectations for quality verification, and stronger biosecurity governance. Regional adoption patterns reflect differences in research infrastructure, biomanufacturing capacity, policy support, and workforce development, while major country and economic group dynamics show that gene synthesis is increasingly tied to national innovation, health security, and bioeconomy strategies. Industry leaders that combine technical excellence with responsible screening, secure data handling, workflow integration, and application-specific expertise will be best positioned to support the next phase of synthetic biology. As gene synthesis becomes faster, more accessible, and more deeply integrated with AI and automated laboratories, the most durable advantage will come from delivering trusted, compliant, reproducible, and scientifically validated DNA solutions for complex biological challenges.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Gene Synthesis Market, by Product
7.1. Introduction
7.2. Instruments
7.2.1. Automated Cloning Instruments
7.2.2. DNA Synthesizers
7.2.3. Microarray Platforms
7.2.4. Thermal Cyclers
7.3. Reagents & Consumables
7.3.1. Buffers & Other Consumables
7.3.2. Enzymes & Kits
7.3.3. Oligonucleotides
7.4. Services
7.4.1. Basic Gene Synthesis
7.4.2. Gene Cloning
7.4.3. Mutagenesis Services
8. Gene Synthesis Market, by Technology
8.1. Introduction
8.2. Chemical Synthesis
8.2.1. H-Phosphonate Synthesis
8.2.2. Phosphoramidite Synthesis
8.3. Enzymatic Synthesis
8.3.1. Gibson Assembly
8.3.2. Golden Gate Assembly
8.3.3. Ligase Chain Reaction
8.4. PCR Based Synthesis
9. Gene Synthesis Market, by Gene Length
9.1. Introduction
9.2. Medium Gene Sequences (1-5 kb)
9.3. Long Gene Sequences (>5 kb)
9.4. Short Gene Sequences (< 1 kb)
10. Gene Synthesis Market, by Application
10.1. Introduction
10.2. Antibody & Vaccine Production
10.3. Industrial Biotechnology
10.4. Molecular Diagnostics
10.5. Stem Cell & Cell Line Engineering
10.6. Synthetic Biology
11. Gene Synthesis Market, by End-User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Clinical Diagnostics Laboratories
11.4. Contract Research Organizations
11.5. Pharmaceutical & Biotechnology Companies
12. Gene Synthesis Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Gene Synthesis Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Gene Synthesis Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agilent Technologies, Inc.
16.2. Ansa Biotechnologies Inc.
16.3. ATUM, Inc.
16.4. Azenta Life Sciences, Inc.
16.5. Bio Basic Inc.
16.6. BioCat GmbH
16.7. Biomatik Corporation
16.8. Bioneer Corporation
16.9. Camena Bioscience
16.10. DNA Script SA
16.11. Elegen Corporation
16.12. Eurofins Scientific SE
16.13. Evonetix Ltd.
16.14. GenScript Biotech Corporation
16.15. Integrated DNA Technologies, Inc.
16.16. Macrogen Inc.
16.17. Merck KGaA
16.18. OriGene Technologies, Inc.
16.19. ProMab Biotechnologies, Inc.
16.20. ProteoGenix SAS
16.21. Quintara Biosciences
16.22. Synbio Technologies Inc.
16.23. Telesis Bio, Inc.
16.24. Thermo Fisher Scientific Inc.
16.25. Twist Bioscience Corporation
List of Figures
FIGURE 1. GLOBAL GENE SYNTHESIS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL GENE SYNTHESIS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL GENE SYNTHESIS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL GENE SYNTHESIS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2025 VS 2032 (%)
FIGURE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL GENE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL GENE SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED CLONING INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED CLONING INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED CLONING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DNA SYNTHESIZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DNA SYNTHESIZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DNA SYNTHESIZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MICROARRAY PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MICROARRAY PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MICROARRAY PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL THERMAL CYCLERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL THERMAL CYCLERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL THERMAL CYCLERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BUFFERS & OTHER CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BUFFERS & OTHER CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BUFFERS & OTHER CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ENZYMES & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ENZYMES & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ENZYMES & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BASIC GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BASIC GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BASIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GENE CLONING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GENE CLONING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GENE CLONING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MUTAGENESIS SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MUTAGENESIS SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MUTAGENESIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CHEMICAL SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL H-PHOSPHONATE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL H-PHOSPHONATE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL H-PHOSPHONATE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PHOSPHORAMIDITE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PHOSPHORAMIDITE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PHOSPHORAMIDITE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ENZYMATIC SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ENZYMATIC SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ENZYMATIC SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GIBSON ASSEMBLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GIBSON ASSEMBLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GIBSON ASSEMBLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GOLDEN GATE ASSEMBLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GOLDEN GATE ASSEMBLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GOLDEN GATE ASSEMBLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL LIGASE CHAIN REACTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL LIGASE CHAIN REACTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL LIGASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PCR BASED SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PCR BASED SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PCR BASED SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL MEDIUM GENE SEQUENCES (1-5 KB) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL MEDIUM GENE SEQUENCES (1-5 KB) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MEDIUM GENE SEQUENCES (1-5 KB) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL LONG GENE SEQUENCES (>5 KB) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL LONG GENE SEQUENCES (>5 KB) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL LONG GENE SEQUENCES (>5 KB) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL SHORT GENE SEQUENCES (< 1 KB) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL SHORT GENE SEQUENCES (< 1 KB) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL SHORT GENE SEQUENCES (< 1 KB) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ANTIBODY & VACCINE PRODUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ANTIBODY & VACCINE PRODUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ANTIBODY & VACCINE PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL INDUSTRIAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL INDUSTRIAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL INDUSTRIAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL STEM CELL & CELL LINE ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL STEM CELL & CELL LINE ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL STEM CELL & CELL LINE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CLINICAL DIAGNOSTICS LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CLINICAL DIAGNOSTICS LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CLINICAL DIAGNOSTICS LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 119. EUROPE GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. EUROPE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 121. EUROPE GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 122. EUROPE GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 123. EUROPE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 124. EUROPE GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 125. EUROPE GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 126. EUROPE GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 127. EUROPE GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 128. EUROPE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. EUROPE GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 152. AFRICA GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 154. AFRICA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 155. AFRICA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 156. AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 157. AFRICA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 158. AFRICA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 159. AFRICA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 160. AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 161. AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 175. NATO GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. NATO GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 177. NATO GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 178. NATO GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 179. NATO GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 180. NATO GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 181. NATO GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 182. NATO GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 183. NATO GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 184. NATO GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. NATO GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 186. G7 GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 187. G7 GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 188. G7 GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 189. G7 GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 190. G7 GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 191. G7 GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 192. G7 GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 193. G7 GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 194. G7 GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 195. G7 GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. G7 GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 197. BRICS GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 198. BRICS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 199. BRICS GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 200. BRICS GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 201. BRICS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 202. BRICS GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 203. BRICS GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 204. BRICS GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 205. BRICS GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 206. BRICS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. BRICS GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 219. ASEAN GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 220. ASEAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 221. ASEAN GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 222. ASEAN GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 223. ASEAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 224. ASEAN GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 225. ASEAN GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 226. ASEAN GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 227. ASEAN GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 228. ASEAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 229. ASEAN GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 230. GCC GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 231. GCC GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 232. GCC GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 233. GCC GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 234. GCC GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 235. GCC GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 236. GCC GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 237. GCC GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 238. GCC GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 239. GCC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. GCC GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 241. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 242. CHINA GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 243. CHINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 244. CHINA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 245. CHINA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 246. CHINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 247. CHINA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 248. CHINA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 249. CHINA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 250. CHINA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 251. CHINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. CHINA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 254. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 255. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 257. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 258. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 261. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 264. JAPAN GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 265. JAPAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 266. JAPAN GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 267. JAPAN GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 268. JAPAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 269. JAPAN GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 270. JAPAN GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 271. JAPAN GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 272. JAPAN GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 273. JAPAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 274. JAPAN GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 275. INDIA GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 276. INDIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 277. INDIA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 278. INDIA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 279. INDIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 280. INDIA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 281. INDIA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 282. INDIA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 283. INDIA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 284. INDIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 285. INDIA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 286. GERMANY GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 287. GERMANY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 288. GERMANY GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 289. GERMANY GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 290. GERMANY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 291. GERMANY GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 292. GERMANY GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 293. GERMANY GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 294. GERMANY GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 295. GERMANY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 296. GERMANY GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 297. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 298. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 299. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 300. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 301. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 302. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 303. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 304. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 305. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 306. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 307. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 308. AUSTRALIA GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 309. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 310. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 311. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 312. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 313. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 314. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 315. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 316. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 317. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 318. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 319. FRANCE GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 320. FRANCE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 321. FRANCE GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 322. FRANCE GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 323. FRANCE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 324. FRANCE GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 325. FRANCE GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 326. FRANCE GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 327. FRANCE GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 328. FRANCE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 329. FRANCE GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 330. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 331. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 332. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 333. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 334. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 335. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 336. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 337. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 338. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 339. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 340. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 341. ITALY GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 342. ITALY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 343. ITALY GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 344. ITALY GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 345. ITALY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 346. ITALY GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 347. ITALY GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 348. ITALY GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 349. ITALY GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 350. ITALY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 351. ITALY GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 352. CANADA GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 353. CANADA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 354. CANADA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 355. CANADA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 356. CANADA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 357. CANADA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 358. CANADA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 359. CANADA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 360. CANADA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 361. CANADA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 362. CANADA GENE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 363. RUSSIA GENE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 364. RUSSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 365. RUSSIA GENE SYNTHESIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 366. RUSSIA GENE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 367. RUSSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 368. RUSSIA GENE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 369. RUSSIA GENE SYNTHESIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 370. RUSSIA GENE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 371. RUSSIA GENE SYNTHESIS MARKET SIZE, BY GENE LENGTH, 2018-2032 (USD MILLION)
TABLE 372. RUSSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 373. RUSSIA GENE SYNTHESIS MARKET SIZE, BY END-USER

Companies Mentioned

  • Agilent Technologies, Inc.
  • Ansa Biotechnologies Inc.
  • ATUM, Inc.
  • Azenta Life Sciences, Inc.
  • Bio Basic Inc.
  • BioCat GmbH
  • Biomatik Corporation
  • Bioneer Corporation
  • Camena Bioscience
  • DNA Script SA
  • Elegen Corporation
  • Eurofins Scientific SE
  • Evonetix Ltd.
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • Macrogen Inc.
  • Merck KGaA
  • OriGene Technologies, Inc.
  • ProMab Biotechnologies, Inc.
  • ProteoGenix SAS
  • Quintara Biosciences
  • Synbio Technologies Inc.
  • Telesis Bio, Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

Table Information

Report AttributeDetails
No. of Pages194
PublishedJuly 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.02 Billion
Forecasted Market Value ( USD ) by 2032 $ 7.51 Billion
Compound Annual Growth Rate16.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Gene Synthesis Service Market - Global Forecast 2026-2032 - Product Image

Gene Synthesis Service Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Custom Gene Synthesis Service Market - Global Forecast 2026-2032 - Product Image

Custom Gene Synthesis Service Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Gene Synthesis (Research Use) - Global Strategic Business Report - Product Image

Gene Synthesis (Research Use) - Global Strategic Business Report

  • Report
  • 565 Pages
  • Global
From
Gene Synthesis & DNA Synthesis Service Global Market Insights 2026, Analysis and Forecast to 2031 - Product Image

Gene Synthesis & DNA Synthesis Service Global Market Insights 2026, Analysis and Forecast to 2031

  • Report
  • 107 Pages
  • Global
From
Gene Synthesis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Gene Synthesis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From

About the Gene Synthesis Market

Gene Synthesis is a technology used in genomics to create custom DNA sequences. It involves synthesizing a gene from its component nucleotides, which are then assembled into a single strand of DNA. The technology is used in a variety of applications, including gene therapy, drug discovery, and agricultural biotechnology. It is also used to create custom DNA libraries for research and development. Gene Synthesis is a rapidly growing market, driven by advances in sequencing technology and the increasing demand for custom DNA sequences. The technology is used in a variety of industries, including pharmaceuticals, biotechnology, and agriculture. It is also used in academic research and in the development of new diagnostic tests. Companies in the Gene Synthesis market include GenScript, DNA2.0, Twist Bioscience, Eurofins Genomics, and Genewiz. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.